£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

Erythropoietin Drugs US Outlook 2023-2028 Study Report

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 24 days · 24 data points (no recent data)

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 11 August 2026 16 August 2026 22 August 2026 28 August 2026 03 September 2026
View at Amazon ↗

Price data last checked 67 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 24 days • 1 price levels

Days at Price
24 days 0 6 12 18 24 £520 Days at Price

Price Analysis

Most common price: £520 (24 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 24 days

Description

This comprehensive study provides a detailed outlook for erythropoietin drugs in the United States from 2023 to 2028. It focuses on latent demand estimates, also known as potential industry earnings (P.I.E.), across approximately 12,600 cities. By providing data on the percent share each city holds relative to its state and the nation, this report offers comparative benchmarks for market analysis. Designed for professionals, the statistical approach uses econometric models to help guide distribution and sales force strategies. This data-driven resource allows users to evaluate specific geographic markets against others to optimize industry planning and resource allocation throughout the United States.

Key Features

Covers the latent demand outlook for erythropoietin drugs across the United States from 2023 to 2028.

Provides potential industry earnings (P.I.E.) estimates for approximately 12,600 cities.

Includes comparative benchmarks showing the percent share of each city relative to its state and the entire country.

Uses econometric models to support data-driven distribution and sales force strategies.

Offers detailed market insights across various states and cities for precise geographic analysis.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2016-2021 Outlook for Erythropoietins in the United States
99% match

The 2016-2021 Outlook for Erythropoietins in the United States

£595.00 28 Aug 2026
Erythropoietins Outlook 2016-2021 - Greater China Study
99% match

Erythropoietins Outlook 2016-2021 - Greater China Study

£595.00 25 Aug 2026
The 2023-2028 Outlook for Erythropoietin Drugs in China
99% match

The 2023-2028 Outlook for Erythropoietin Drugs in China

£495.00 28 Aug 2026
Erythropoietins Outlook 2013-2018 - North America & Caribbean
98% match

Erythropoietins Outlook 2013-2018 - North America & Caribbean

£325.00 06 Nov 2026
The 2016 Report on Erythropoietins: World Market Segmentation by City
98% match

The 2016 Report on Erythropoietins: World Market Segmentation by City

£995.00 25 Aug 2026
Erythropoietins in the Middle East (2009-2014) Econometric Study
98% match

Erythropoietins in the Middle East (2009-2014) Econometric Study

£325.00 03 Sep 2026
Erythropoietin Drugs US Zip Code Outlook 2023-2028 Study
97% match

Erythropoietin Drugs US Zip Code Outlook 2023-2028 Study

£490.00 03 Sep 2026
US Myeloproliferative Disorder Drug Outlook 2023-2028
97% match

US Myeloproliferative Disorder Drug Outlook 2023-2028

£520.00 02 Sep 2026
US Hematology and Oncology Products Market Outlook 2016-2021
97% match

US Hematology and Oncology Products Market Outlook 2016-2021

£595.00 18 Sep 2026
Hematology and Oncology Products in India Outlook 2016-2021
97% match

Hematology and Oncology Products in India Outlook 2016-2021

£595.00 07 Nov 2026
Myeloproliferative Disorder Drugs Outlook in India 2023-2028
97% match

Myeloproliferative Disorder Drugs Outlook in India 2023-2028

£515.00 28 Aug 2026
The 2016-2021 Outlook for Hematology Instruments and Reagents in India
97% match

The 2016-2021 Outlook for Hematology Instruments and Reagents in India

£595.00 26 Aug 2026
The 2016-2021 Outlook for Hematology and Oncology Products in Greater China
97% match

The 2016-2021 Outlook for Hematology and Oncology Products in Greater China

£595.00 01 Oct 2026
2023-2028 US Advanced Therapy Medicinal Products Outlook
97% match

2023-2028 US Advanced Therapy Medicinal Products Outlook

£520.00 05 Nov 2026
The 2016-2021 Outlook for Hematology Instruments and Reagents in the United States
97% match

The 2016-2021 Outlook for Hematology Instruments and Reagents in the United States

£595.00 01 Oct 2026
US Bone Marrow Transplant Outlook 2023-2028 Study Report
97% match

US Bone Marrow Transplant Outlook 2023-2028 Study Report

£520.00 05 Nov 2026
Advanced Therapy Medicinal Products Outlook India 2023-2028
97% match

Advanced Therapy Medicinal Products Outlook India 2023-2028

£515.00 06 Nov 2026
2023-2028 US E-Paper Outlook - Market Demand Study
97% match

2023-2028 US E-Paper Outlook - Market Demand Study

£520.00 06 Nov 2026
The 2026-2031 World Outlook for Autologous Bone Marrow Transplants
97% match

The 2026-2031 World Outlook for Autologous Bone Marrow Transplants

£885.00 06 Nov 2026
Digital Therapeutics Sales Outlook India 2023-2028 Study
97% match

Digital Therapeutics Sales Outlook India 2023-2028 Study

£515.00 25 Aug 2026
The 2016-2021 Outlook for Hematology Instruments and Reagents in Greater China
97% match

The 2016-2021 Outlook for Hematology Instruments and Reagents in Greater China

£595.00 02 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
Women's Health Apps Outlook 2023-2028 - US Market Study
97% match

Women's Health Apps Outlook 2023-2028 - US Market Study

£520.00 05 Nov 2026
The 2016-2021 Outlook for Hematology and Oncology Products in Japan
97% match

The 2016-2021 Outlook for Hematology and Oncology Products in Japan

£595.00 06 Nov 2026